1Brian G,Taylor H.Cataract blindness-challenges for the 21st century.Bull World Health Organ,2001,79:249-256.
2Huang S,Zheng Y,Foster PJ,et al.Prevalence and causes of visual impairment in Chinese adults in urban southern China.Arch Ophthalmol,2009,127:1362-1367.
7Hegde KR,Henein MG,Varma SD.Establishment of mouse as an animal model for study of diabetic cataracts:Biochemical studies.Diabetes Obes Metab,2003,5:113-119.
9Derham BK,Harding JJ.q-crystallin as a molecular chaperone.Prog Retin Eye Res,1999,18:463-509.
10Swamy Mruthinti S,Shaw SM,Zhao HR,et al.Evidence of a glycemic threshold for the development of cataracts in diabetic rats.Curr Eye Res,1999,18:423-429.
4Ito Y,Cai H,Koizumi Y,et al.Correlationbetween prevention of cataract development by disulfiram and facts of selenium in selenit-treated rats [J].Curr Eye Res,1999,18:292-299.
5Obrosova IG,Stevens MJ.Effect of dietary taurine supplementation on GSH and NAD(P)-redox statu,lipid peroxidation,and energy metabolism in diabetic precataractoos lens [J].Invest Ophthalmol Vis Sci,1999,40:680-688.
6Trevivhick JR,Mitton KP,Kilic F,et al.Modelling cortical cataractogenesis:does model diabetic rat cataract early loss of taurine and amino acids decrease lens antioxidant activity? [J].Exp Eye Res,1998,67(suppl 1):S2.
7Harding JJ.Can drugs or micronutrients prevent cataract? [J].Drugs Aging,2001,18(7):473-486.
9Schatz H, Atienza D, Mcdonald HR,et al. Sever diabetic retinopathy after cataract surgery. Am J Ophthalmol 2010 ,117(3 ) :314-321.
10Goebbels M, Spitznas M. Endothdial balTior function after phacoenmlsfication: a comparison between diabetic, and non-diabetes patient. Grades Arch Clin Exp Ophthalmol 2009 ,229 ( 3 ) :254-257.
